PVLA
Palvella Therapeutics
PVLA
PVLA
73 hedge funds and large institutions have $102M invested in Palvella Therapeutics in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 11 increasing their positions, 29 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 31
62% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 29
Holders
73
Holding in Top 10
–
Calls
$2.1M
Puts
$1.84M
Top Buyers
| 1 | +$11.3M | |
| 2 | +$3.83M | |
| 3 | +$3.55M | |
| 4 |
Morgan Stanley
New York
|
+$3.28M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$2.51M |
Top Sellers
| 1 | -$9.11M | |
| 2 | -$4.64M | |
| 3 | -$2.86M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$2.63M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.46M |